Page last updated: 2024-10-21

3-aminobenzamide and Meningitis, Pneumococcal

3-aminobenzamide has been researched along with Meningitis, Pneumococcal in 1 studies

Meningitis, Pneumococcal: An acute purulent infection of the meninges and subarachnoid space caused by Streptococcus pneumoniae, most prevalent in children and adults over the age of 60. This illness may be associated with OTITIS MEDIA; MASTOIDITIS; SINUSITIS; RESPIRATORY TRACT INFECTIONS; sickle cell disease (ANEMIA, SICKLE CELL); skull fractures; and other disorders. Clinical manifestations include FEVER; HEADACHE; neck stiffness; and somnolence followed by SEIZURES; focal neurologic deficits (notably DEAFNESS); and COMA. (From Miller et al., Merritt's Textbook of Neurology, 9th ed, p111)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Koedel, U1
Winkler, F1
Angele, B1
Fontana, A1
Pfister, HW1

Other Studies

1 other study available for 3-aminobenzamide and Meningitis, Pneumococcal

ArticleYear
Meningitis-associated central nervous system complications are mediated by the activation of poly(ADP-ribose) polymerase.
    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2002, Volume: 22, Issue:1

    Topics: Animals; Benzamides; Brain; Brain Chemistry; Cell Line; Central Nervous System Diseases; Disease Mod

2002